Drug recall · November 27, 2024
Triamcinolone Acetonide Cream USP recall
Why: Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05
- Lots / codes
Lot #: 2024154238, 2024174344, Exp. Date 3/31/2026
- Quantity
- 10,872 jars
- Company
- Padagis US LLC, Minneapolis, MN
- Distribution
- Nationwide in the USA
- Initiated
- October 11, 2024 · Voluntary: Firm initiated
- Classified
- November 18, 2024
- Reported
- November 27, 2024
- Ended
- September 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Triamcinolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.